Start triage first, then route to emergency care.
Need urgent help? Start triage first, then route to emergency care.
Roxee Medication Guide
Medication reference facts with explicit FDA-approval, off-label, source-limited, and safety context. Roxee does not sell, prescribe, or dispense medications.
Veterinary professional?
These are the reference facts Roxee uses on browse cards and quick facts.
Sponsor, product, and application records imported from Animal Drugs @ FDA.
openFDA reaction terms and case summaries are supporting evidence, not proof of causality.
Drug type: Generic ingredient • Branded profile • Regulatory linkage incomplete
Species: Both
Approval status: Official document linked, regulatory match incomplete. An official source document is available, but Roxee has not linked this row to a confirmed FDA animal-drug application or product record yet.
Merged from the current Roxee medication system with field-level provenance, freshness, and completeness tracking.
Bravecto (fluralaner) Chews are approved for dogs and puppies to treat and prevent flea infestations and to treat and control labeled tick infestations for the labeled duration. Species commonly shown: Dogs.
Bravecto (fluralaner) Chews are approved for dogs and puppies to treat and prevent flea infestations and to treat and control labeled tick infestations for the labeled duration.
Administer orally with food on the labeled interval and dose by the dog's body weight; owners should follow the veterinarian's prescription and label directions.
The official Bravecto Chews label lists no known contraindications.
Top reported reactions (openFDA): Vomiting, Lack of efficacy (ectoparasite) - flea, Lack of efficacy (ectoparasite) - tick NOS, Emesis (multiple), Lethargy (see also Central nervous system depression in 'Neurological'), Diarrhoea.
Choose a pet, confirm current or past, and optionally add reminder notes.
Sign in to save this medication to your pet profile.
Sign in to continueStart here first for the safest next-step summary before the deeper medication detail.
Used for:
Your vet decides this. Here's what owners typically ask/watch for.
Dosing note:
Exact dosing depends on your pet's species, weight, and health status. Use your veterinarian's instructions for the exact dose and schedule.
What to watch for:
When to call the vet:
What to tell or ask your vet today:
A source-aware map of what to know, what is uncertain, and what to verify with your veterinarian.
Roxee has limited cited overview evidence for Fluralaner 13.64% Chew Tablets; use the official documents and your veterinarian's instructions for product-specific decisions.
32 tracked reaction signals; 32 reported cases; 18 serious reports; 2 species groups. These are reporting and label-derived signals for interpretation with a veterinarian.
Adverse-event reports help form a watch list, but they do not prove the medication caused the reaction and they are not a risk ranking between medications.
Official labels, package inserts, and reviewed summaries carry more weight than isolated reports.
Case reports and openFDA terms are useful for pattern awareness, but they are incomplete, can include multiple exposures, and do not estimate an individual pet's probability of harm.
Vomiting (1 reports), Eosinopenia (1 reports), Elevated serum alkaline phosphatase (1 reports), Elevated haematocrit (1 reports), Elevated alanine aminotransferase (1 reports)
Digestive (5), Neurologic (1), Behavior (2), Other (24)
Dog (28 reports), Cat (4 reports)
Retriever - Labrador (2), Domestic Shorthair (1), ['Beagle', 'Dog (unknown)'] (1), ['Retriever - Labrador', 'Poodle (unspecified)'] (1). These are report metadata, not proof that a breed is at higher risk.
Verify whether Fluralaner 13.64% Chew Tablets fits the pet's species, current diagnosis, age, weight, organ status, pregnancy/lactation status, and concurrent medications.
Separate label-backed warnings from adverse-event reports and owner observations before changing the plan.
Vomiting, Eosinopenia, Elevated serum alkaline phosphatase
Repeated vomiting or diarrhea. Severe lethargy (hard to wake, very low energy). Collapse or fainting.
Review status / Updated / Sources
Review status: Clinical reviewer not listed
Updated: April 22, 2026, 10:07 AM UTC
Side effects to monitor:
Most reported reactions:
Emergency warning signs:
Source-backed clinical checkpoints for quick review.
Official label facts first, then secondary summaries. Marketing content is separated below.
Snapshot first, detailed rows second. This section summarizes signal data and is not a diagnosis.
Filter stored openFDA reports by pet and report attributes. Counts describe reports in this data set, not risk.
Received 2026-03-26 · MSK · MSK
Received 2026-03-24 · MSK · MSK
Received 2026-03-24 · MSK · MSK
Received 2026-03-23 · MSK · MSK
Received 2026-03-23 · MSK · MSK
Received 2026-03-20 · MSK · MSK
Received 2026-03-20 · MSK · MSK
Received 2026-03-19 · MSK · MSK
Received 2026-03-18 · MSK · MSK
Received 2026-03-16 · MSK · MSK
Received 2026-03-16 · MSK · MSK
Received 2026-03-16 · MSK · MSK
Received 2026-03-03 · MSK · MSK
Received 2026-01-29 · MSK · MSK
Received 2026-01-20 · MSK · MSK
Received 2026-01-06 · MSK · MSK
Received 2025-12-23 · MSK · MSK
Received 2025-12-23 · MSK · MSK
Received 2025-12-23 · MSK · MSK
Received 2025-12-20 · MSK · MSK
Received 2025-12-18 · MSK · MSK
Received 2025-12-15 · MSK · MSK
Received 2025-12-10 · MSK · MSK
Received 2025-12-09 · MSK · MSK
Received 2025-12-04 · MSK · MSK
Received 2025-12-04 · MSK · MSK
Received 2025-12-02 · MSK · MSK
Received 2025-12-01 · MSK · MSK
Received 2025-11-25 · MSK · MSK
Received 2025-11-25 · MSK · MSK
Received 2025-11-20 · MSK · MSK
Received 2025-11-19 · MSK · MSK
Received 2025-11-17 · MSK · MSK
Received 2025-11-17 · MSK · MSK
Received 2025-11-17 · MSK · MSK
Tap or hover a reaction to see what it means in plain language.
| Reaction | Body system | Cases | Species | Serious cases |
|---|---|---|---|---|
| Digestive | 1 | Dog | 1 | |
| Other | 1 | Dog | 1 | |
| Other | 1 | Dog | 1 | |
| Other | 1 | Dog | 1 | |
| Other | 1 | Dog | 1 | |
| Other | 1 | Cat | 1 | |
| Other | 1 | Cat | 1 | |
| Digestive | 1 | Cat | 1 |
Species coverage: Dog (28) Cat (4)
| Reaction | Body system | Species | Seriousness | Frequency | Reports |
|---|---|---|---|---|---|
| Digestive | Dog | Serious | - | 1 | |
| Neurologic | Dog | Non-serious | - | 1 | |
| Digestive | Dog | Non-serious | - | 1 | |
| Other | Dog | Serious | - | 1 | |
| Other | Dog | Non-serious | - | 1 | |
| Other | Dog | Non-serious | - | 1 | |
| Other | Dog | Serious | - | 1 | |
| Other | Dog | Serious | - | 1 | |
| Other | Dog | Non-serious | - | 1 | |
| Other | Dog | Non-serious | - | 1 | |
| Other | Dog | Serious | - | 1 | |
| Other | Cat | Serious | - | 1 | |
| Other | Dog | Non-serious | - | 1 | |
| Other | Dog | Non-serious | - | 1 | |
| Other | Cat | Serious | - | 1 | |
| Digestive | Dog | Non-serious | - | 1 | |
| Digestive | Cat | Serious | - | 1 | |
| Other | Cat | Non-serious | - | 1 | |
| Other | Dog | Serious | - | 1 | |
| Other | Dog | Serious | - | 1 | |
| Other | Dog | Non-serious | - | 1 | |
| Other | Dog | Non-serious | - | 1 | |
| Other | Dog | Serious | - | 1 | |
| Other | Dog | Serious | - | 1 | |
| Digestive | Dog | Serious | - | 1 | |
| Other | Dog | Serious | - | 1 | |
| Other | Dog | Serious | - | 1 | |
| Behavior | Dog | Non-serious | - | 1 | |
| Behavior | Dog | Serious | - | 1 | |
| Other | Dog | Serious | - | 1 | |
| Other | Dog | Non-serious | - | 1 | |
| Other | Dog | Serious | - | 1 |
The most useful source links appear first; full previews and metadata stay in the veterinary/professional layer.
Use original documents to confirm product-specific warnings, ingredients, and handling details with your veterinarian.
Full source previews and metadata remain in the veterinary/professional layer.
Official label / PI · Official label
This source does not expose a safe inline preview. Use the original source link for the full document.
Official Bravecto Chews label.
SPL · Structured Product Label
This source does not expose a safe inline preview. Use the original source link for the full document.
FDA Structured Product Label XML for Bravecto Chews.
Canonical medication sections are above. This legacy block remains available for deeper cross-reference without cluttering the primary workflow.
Quick facts and links to official labeling and safety signals.
Diagnosis-code mappings are not available for this medication yet.
Global Pet owner/Vet mode is controlled in the header. This section avoids duplicate in-page persona tabs.
Documents are tiered by source trust: Official, Clinical, Manufacturer, Marketing.
Every non-trivial field is expected to include provenance and update timestamps.
De-duplicated reaction terms grouped by body system from FDA openFDA reports (not verified; does not prove causation).
Showing top 5 for Digestive.
Showing top 5 for Neurologic.
Showing top 5 for Behavior.
Showing top 5 for Other.
Data source: FDA openFDA Animal & Veterinary adverse event reports.
These are individual FDA adverse event reports. They are unverified and do not prove the medication caused the reaction.
Cat, Domestic Shorthair, Male, 11 month, 5.117 kilogram • Drug: MSK, Unknown • Reactions: Suckling disorder NOS, Licking, Skin scab, Peripheral vascular disorder, Pinnal erythema… • Outcome: Outcome Unknown
Dog, ['Beagle', 'Dog (unknown)'], Female, 16 year, 13.6 kilogram • Drug: MSK, Tablet, chewable, Oral, Dose: 1 tablet per animal • Reactions: Vomiting • Outcome: Ongoing
Dog, ['Retriever - Labrador', 'Poodle (unspecified)'], Male, 6 month, 6.985 kilogram • Drug: MSK, Injection, solution, Subcutaneous • Reactions: Vomiting, Generalised itching, Anaphylaxis • Outcome: Ongoing
Dog, ['Saint Bernard Dog', 'Dog (unknown)'], Female, 7 month • Drug: MSK, Unknown • Reactions: Lack of efficacy (bacteria) - Borrelia • Outcome: Outcome Unknown
Dog, ['Dachshund - Standard Long-haired', 'Terrier - Yorkshire'], Female, 14 year, 6.35 kilogram • Drug: MSK, Unassigned, Unknown • Reactions: Seizure NOS • Outcome: Outcome Unknown
Dog, Retriever - Labrador, Male, 10 year, 28.576 kilogram • Drug: MSK, Unassigned, Unknown • Reactions: Limping, Limb weakness, Cough, Neurological signs NOS, Wobbliness… • Outcome: Ongoing
Dog, Retriever - Labrador, Male, 3 year, 28.576 kilogram • Drug: MSK, Unassigned, Unknown • Reactions: Increased salivation, Drowsiness - systemic disorder • Outcome: Outcome Unknown
Dog, Crossbred Canine/dog, Male, 8 year, 22.044 kilogram • Drug: MSK, Unknown • Reactions: Lack of efficacy (endoparasite) - hookworm • Outcome: Outcome Unknown
Data source: FDA openFDA Animal & Veterinary adverse event reports.
No approved overdose-management text is linked yet. If overdose is suspected, contact a veterinarian or emergency clinic immediately.
No approved storage guidance is linked yet for this ingredient. Use manufacturer packaging and veterinary guidance for handling/storage.
Let others know your experience or advice regarding this medication.
This medication has not been reviewed by a veterinarian yet.